APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arthritis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Arthritis Drug Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchArthritis Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Arthritis Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Arthritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arthritis Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Arthritis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Arthritis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arthritis Drug include Celltrion, F. Hoffmann-La Roche, GSK, Pfizer, Eli Lilly, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Arthritis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Arthritis Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Arthritis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Arthritis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Arthritis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Arthritis Drug Market by Company

Celltrion

F. Hoffmann-La Roche

GSK

Pfizer

Eli Lilly

Novartis

Johnson & Johnson

Arthritis Drug Segment by Type

Analgesics

Biological DMARDs

Corticosteroids

Synthetic DMARDs

NSAIDs

Arthritis Drug Segment by Application

Hospital Pharmacies

Drug Stores

Retail Pharmacies

E-Commerce

Arthritis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arthritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arthritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arthritis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Arthritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Analgesics Table 2. Major Company of Biological DMARDs Table 3. Major Company of Corticosteroids Table 4. Major Company of Synthetic DMARDs Table 5. Major Company of NSAIDs Table 6. Global Arthritis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Arthritis Drug Sales by Type (2021-2026) & (k units) Table 8. Global Arthritis Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Arthritis Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Arthritis Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Arthritis Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Arthritis Drug Sales by Type (2027-2032) & (k units) Table 13. Global Arthritis Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Arthritis Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Arthritis Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Arthritis Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Arthritis Drug Sales by Type (2021-2026) & (k units) Table 18. North America Arthritis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Arthritis Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Arthritis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Arthritis Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Arthritis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Arthritis Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Arthritis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Arthritis Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Arthritis Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Arthritis Drug Industry Trends Table 28. Arthritis Drug Industry Drivers Table 29. Arthritis Drug Industry Opportunities and Challenges Table 30. Arthritis Drug Industry Restraints Table 31. Global Arthritis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Arthritis Drug Revenue Market Share by Company (2021-2026) Table 33. Global Arthritis Drug Sales by Company (2021-2026) & (k units) Table 34. Global Arthritis Drug Sales Share by Company (2021-2026) Table 35. Global Arthritis Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Arthritis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Arthritis Drug Major Company Production Sites and Headquarters Table 38. Global Arthritis Drug Company, Product Type & Application Table 39. Global Arthritis Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Arthritis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Arthritis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Arthritis Drug Sales by Region (2021-2026) & (k units) Table 44. Global Arthritis Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Arthritis Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Arthritis Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Arthritis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Arthritis Drug Sales by Region (2027-2032) & (k units) Table 49. Global Arthritis Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Arthritis Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Arthritis Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Arthritis Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Arthritis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Arthritis Drug Sales by Application (2021-2026) & (k units) Table 55. Global Arthritis Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Arthritis Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Arthritis Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Arthritis Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Arthritis Drug Sales by Application (2027-2032) & (k units) Table 60. Global Arthritis Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Arthritis Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Arthritis Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Arthritis Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Arthritis Drug Sales by Application (2021-2026) & (k units) Table 65. North America Arthritis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Arthritis Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Arthritis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Arthritis Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Arthritis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Arthritis Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Arthritis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Arthritis Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Arthritis Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Celltrion Company Information Table 75. Celltrion Business Overview Table 76. Celltrion Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Celltrion Arthritis Drug Product Portfolio Table 78. Celltrion Recent Development Table 79. F. Hoffmann-La Roche Company Information Table 80. F. Hoffmann-La Roche Business Overview Table 81. F. Hoffmann-La Roche Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. F. Hoffmann-La Roche Arthritis Drug Product Portfolio Table 83. F. Hoffmann-La Roche Recent Development Table 84. GSK Company Information Table 85. GSK Business Overview Table 86. GSK Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GSK Arthritis Drug Product Portfolio Table 88. GSK Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Pfizer Arthritis Drug Product Portfolio Table 93. Pfizer Recent Development Table 94. Eli Lilly Company Information Table 95. Eli Lilly Business Overview Table 96. Eli Lilly Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Eli Lilly Arthritis Drug Product Portfolio Table 98. Eli Lilly Recent Development Table 99. Novartis Company Information Table 100. Novartis Business Overview Table 101. Novartis Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Novartis Arthritis Drug Product Portfolio Table 103. Novartis Recent Development Table 104. Johnson & Johnson Company Information Table 105. Johnson & Johnson Business Overview Table 106. Johnson & Johnson Arthritis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Johnson & Johnson Arthritis Drug Product Portfolio Table 108. Johnson & Johnson Recent Development Table 109. North America Arthritis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 110. North America Arthritis Drug Sales by Country (2021-2026) & (k units) Table 111. North America Arthritis Drug Sales Market Share by Country (2021-2026) Table 112. North America Arthritis Drug Sales Forecast by Country (2027-2032) & (k units) Table 113. North America Arthritis Drug Sales Market Share Forecast by Country (2027-2032) Table 114. North America Arthritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. North America Arthritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 116. North America Arthritis Drug Market Share by Country (2021-2026) Table 117. North America Arthritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. North America Arthritis Drug Market Share Forecast by Country (2027-2032) Table 119. Europe Arthritis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 120. Europe Arthritis Drug Sales by Country (2021-2026) & (k units) Table 121. Europe Arthritis Drug Sales Market Share by Country (2021-2026) Table 122. Europe Arthritis Drug Sales Forecast by Country (2027-2032) & (k units) Table 123. Europe Arthritis Drug Sales Market Share Forecast by Country (2027-2032) Table 124. Europe Arthritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Europe Arthritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. Europe Arthritis Drug Market Share by Country (2021-2026) Table 127. Europe Arthritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Europe Arthritis Drug Market Share Forecast by Country (2027-2032) Table 129. Asia-Pacific Arthritis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. Asia-Pacific Arthritis Drug Sales by Country (2021-2026) & (k units) Table 131. Asia-Pacific Arthritis Drug Sales Market Share by Country (2021-2026) Table 132. Asia-Pacific Arthritis Drug Sales Forecast by Country (2027-2032) & (k units) Table 133. Asia-Pacific Arthritis Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Arthritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Arthritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Asia-Pacific Arthritis Drug Market Share by Country (2021-2026) Table 137. Asia-Pacific Arthritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Asia-Pacific Arthritis Drug Market Share Forecast by Country (2027-2032) Table 139. Latin America Arthritis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Latin America Arthritis Drug Sales by Country (2021-2026) & (k units) Table 141. Latin America Arthritis Drug Sales Market Share by Country (2021-2026) Table 142. Latin America Arthritis Drug Sales Forecast by Country (2027-2032) & (k units) Table 143. Latin America Arthritis Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Latin America Arthritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Latin America Arthritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Latin America Arthritis Drug Market Share by Country (2021-2026) Table 147. Latin America Arthritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Latin America Arthritis Drug Market Share Forecast by Country (2027-2032) Table 149. Middle East and Africa Arthritis Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Middle East and Africa Arthritis Drug Sales by Country (2021-2026) & (k units) Table 151. Middle East and Africa Arthritis Drug Sales Market Share by Country (2021-2026) Table 152. Middle East and Africa Arthritis Drug Sales Forecast by Country (2027-2032) & (k units) Table 153. Middle East and Africa Arthritis Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Arthritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Arthritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Arthritis Drug Market Share by Country (2021-2026) Table 157. Middle East and Africa Arthritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Middle East and Africa Arthritis Drug Market Share Forecast by Country (2027-2032) Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Arthritis Drug Distributors List Table 162. Arthritis Drug Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Arthritis Drug Image Figure 2. Global Arthritis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arthritis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Arthritis Drug Sales (2021-2032) & (k units) Figure 5. Analgesics Image Figure 6. Global Analgesics Sales YoY Growth (2021-2032) & (k units) Figure 7. Biological DMARDs Image Figure 8. Global Biological DMARDs Sales YoY Growth (2021-2032) & (k units) Figure 9. Corticosteroids Image Figure 10. Global Corticosteroids Sales YoY Growth (2021-2032) & (k units) Figure 11. Synthetic DMARDs Image Figure 12. Global Synthetic DMARDs Sales YoY Growth (2021-2032) & (k units) Figure 13. NSAIDs Image Figure 14. Global NSAIDs Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Arthritis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Arthritis Drug Market Share by Type 2025 VS 2032 Figure 17. North America Arthritis Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Arthritis Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Arthritis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Arthritis Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Arthritis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Arthritis Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Arthritis Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Arthritis Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Arthritis Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Arthritis Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Arthritis Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Drug Stores Image Figure 32. Global Drug Stores Sales YoY Growth (2021-2032) & (k units) Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. E-Commerce Image Figure 36. Global E-Commerce Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Arthritis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Arthritis Drug Market Share by Application 2025 VS 2032 Figure 39. North America Arthritis Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Arthritis Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Arthritis Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Arthritis Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Arthritis Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Arthritis Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Arthritis Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Arthritis Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Arthritis Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Arthritis Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Arthritis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Arthritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Arthritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Arthritis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Arthritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Arthritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Arthritis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Arthritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Arthritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Arthritis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Arthritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Arthritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Arthritis Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Arthritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Arthritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Arthritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Arthritis Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Arthritis Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Biological DMARDs
  • Corticosteroids
  • Synthetic DMARDs
  • NSAIDs
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • E-Commerce
Companies covered
  • Celltrion
  • F. Hoffmann-La Roche
  • GSK
  • Pfizer
  • Eli Lilly
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Arthritis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Arthritis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Arthritis Drug Market by Type
  6. 1.3.1 Analgesics
  7. 1.3.2 Biological DMARDs
  8. 1.3.3 Corticosteroids
  9. 1.3.4 Synthetic DMARDs
  10. 1.3.5 NSAIDs
  11. 1.4 Global Arthritis Drug Market Size by Type
  12. 1.4.1 Global Arthritis Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Arthritis Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Arthritis Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Arthritis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Arthritis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Arthritis Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Arthritis Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Arthritis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Arthritis Drug Industry Trends
  2. 2.2 Arthritis Drug Industry Drivers
  3. 2.3 Arthritis Drug Industry Opportunities and Challenges
  4. 2.4 Arthritis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Arthritis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Arthritis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Arthritis Drug Price (2021-2026)
  4. 3.4 Global Arthritis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arthritis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Arthritis Drug Company, Product Type & Application
  7. 3.7 Global Arthritis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arthritis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arthritis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arthritis Drug Tier 1, Tier 2, and Tier 3
4 Arthritis Drug Regional Status and Outlook
  1. 4.1 Global Arthritis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Arthritis Drug Historic Market Size by Region
  3. 4.2.1 Global Arthritis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Arthritis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Arthritis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Arthritis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Arthritis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Arthritis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Arthritis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Arthritis Drug by Application
  1. 5.1 Arthritis Drug Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 E-Commerce
  6. 5.2 Global Arthritis Drug Market Size by Application
  7. 5.2.1 Global Arthritis Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Arthritis Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Arthritis Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Arthritis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Arthritis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Arthritis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Arthritis Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Arthritis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Celltrion
  2. 6.1.1 Celltrion Company Information
  3. 6.1.2 Celltrion Business Overview
  4. 6.1.3 Celltrion Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Celltrion Arthritis Drug Product Portfolio
  6. 6.1.5 Celltrion Recent Developments
  7. 6.2 F. Hoffmann-La Roche
  8. 6.2.1 F. Hoffmann-La Roche Company Information
  9. 6.2.2 F. Hoffmann-La Roche Business Overview
  10. 6.2.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio
  12. 6.2.5 F. Hoffmann-La Roche Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Arthritis Drug Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Arthritis Drug Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Arthritis Drug Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Arthritis Drug Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Johnson & Johnson
  38. 6.7.1 Johnson & Johnson Company Information
  39. 6.7.2 Johnson & Johnson Business Overview
  40. 6.7.3 Johnson & Johnson Arthritis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Johnson & Johnson Arthritis Drug Product Portfolio
  42. 6.7.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Arthritis Drug Sales by Country
  2. 7.1.1 North America Arthritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Arthritis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Arthritis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Arthritis Drug Market Size by Country
  6. 7.2.1 North America Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Arthritis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Arthritis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Arthritis Drug Sales by Country
  2. 8.1.1 Europe Arthritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Arthritis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Arthritis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Arthritis Drug Market Size by Country
  6. 8.2.1 Europe Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Arthritis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Arthritis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Arthritis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Arthritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Arthritis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Arthritis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Arthritis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Arthritis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Arthritis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Arthritis Drug Sales by Country
  2. 10.1.1 South America Arthritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Arthritis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Arthritis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Arthritis Drug Market Size by Country
  6. 10.2.1 South America Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Arthritis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Arthritis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Arthritis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Arthritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Arthritis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Arthritis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Arthritis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Arthritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Arthritis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Arthritis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Arthritis Drug Value Chain Analysis
  2. 12.1.1 Arthritis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Arthritis Drug Production Mode & Process
  7. 12.2 Arthritis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Arthritis Drug Distributors
  10. 12.2.3 Arthritis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst